0.9% SODIUM CHLORIDE IRRIGATION USP 0.9 % — DIN 01963937
SODIUM CHLORIDE : 0.9 % · B. BRAUN MEDICAL INC · SOLUTION · wholesale supply in Canada
Health Canada status: DORMANT
What is 0.9% SODIUM CHLORIDE IRRIGATION USP?
0.9% SODIUM CHLORIDE IRRIGATION USP 0.9 % contains SODIUM CHLORIDE : 0.9 %. It is listed in the Health Canada Drug Product Database under DIN 01963937, held by B. BRAUN MEDICAL INC, supplied as SOLUTION for IRRIGATION administration. Health Canada currently lists it as dormant, status dated 08-Jul-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
Is there a generic Sodium Chloride in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
7 holders have a Canadian DIN containing Sodium Chloride, across 9 DINs, of which 2 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| ICU MEDICAL CANADA INC | 2 | 1 | SODIUM CHLORIDE IRRIGATION USP | Sourceable in Canada |
| BAXTER CORPORATION | 1 | 1 | 0.9% SODIUM CHLORIDE IRRIGATION, USP | Sourceable in Canada |
| B. BRAUN MEDICAL INC | 2 | 0 | 0.9% SODIUM CHLORIDE IRRIGATION USP | No marketed DIN |
| ASTRAZENECA CANADA INC | 1 | 0 | SODIUM CHLORIDE IRRIGATION SOLN 0.9% | No marketed DIN |
| COLOPLAST CORP. | 1 | 0 | SEA CLENS WOUND CLEANSER | No marketed DIN |
| INGRAM AND BELL INC. | 1 | 0 | SODIUM CHLORIDE TAB 1GM | No marketed DIN |
| THE RITEDOSE CORPORATION | 1 | 0 | SODIUM CHLORIDE INHALATION SOLUTION USP 0.9% | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 0.9 % |
|---|---|
| Dosage form | SOLUTION |
| Route | IRRIGATION |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Sodium Chloride |
|---|---|
| ATC code | B05CB01 |
| AHFS class | 40:36.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 01963937 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1963937 |
| Brand name | 0.9% SODIUM CHLORIDE IRRIGATION USP |
| Generic / active ingredient | SODIUM CHLORIDE : 0.9 % |
| Market authorization holder | B. BRAUN MEDICAL INC |
| Health Canada schedule | Ethical |
| ATC code | B05CB01 |
| ATC anatomical main group | B — Blood and blood-forming organs |
| ATC therapeutic subgroup | B05CB |
| Current status | DORMANT |
| Status date | 08-Jul-2019 |
| Original market date | 1992-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Sodium Chloride in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
2 of 9 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| 0.9% SODIUM CHLORIDE IRRIGATION, USP | 900 MG / 100 ML | SOLUTION | BAXTER CORPORATION | MARKETED | 00786160 |
| SODIUM CHLORIDE IRRIGATION USP | 9 MG | SOLUTION | ICU MEDICAL CANADA INC | MARKETED | 00037834 |
| 0.9% SODIUM CHLORIDE IRRIGATION USP | 0.9 % | SOLUTION | B. BRAUN MEDICAL INC | APPROVED | 02530600 |
| SEA CLENS WOUND CLEANSER | 0.7 % | LIQUID | COLOPLAST CORP. | CANCELLED POST MARKET | 02230331 |
| SODIUM CHLORIDE INHALATION SOLUTION USP 0.9% | 0.9 % | SOLUTION | THE RITEDOSE CORPORATION | CANCELLED POST MARKET | 02058235 |
| SODIUM CHLORIDE IRRIGATION SOLN 0.9% | 9 MG | LIQUID | ASTRAZENECA CANADA INC | CANCELLED POST MARKET | 00709611 |
| SODIUM CHLORIDE IRRIGATION USP | 9 MG | SOLUTION | ICU MEDICAL CANADA INC | CANCELLED POST MARKET | 00037826 |
| SODIUM CHLORIDE TAB 1GM | 1 G | TABLET | INGRAM AND BELL INC. | CANCELLED POST MARKET | 00120030 |
2 · Same class — other molecules in ATC B05CB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Combinations | BALANCED SALT SOLUTION · ELLIOTT'S SOLUTION A · LACTATED RINGER'S IRRIGATION · LACTATED RINGER'S IRRIGATION SOL · +6 more | 13 | 3 | Yes |
| Sodium Chloride | 0.9% SODIUM CHLORIDE IRRIGATION USP · 0.9% SODIUM CHLORIDE IRRIGATION, USP · SEA CLENS WOUND CLEANSER · SODIUM CHLORIDE INHALATION SOLUTION USP 0.9% · +3 more | 9 | 2 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC B05C
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| B05CX | Combinations · Glycine · Mannitol | 6 | 4 |
| B05CA | Combinations | 1 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.